Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Greenlee

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamidesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|November 12, 1993
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylatesW T Ashton, S M Hutchins, W J Greenlee, et al.
European Journal of Pharmacology|December 29, 1995
In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptorsS D Kivlighn, G J Zingaro, R A Gabel, et al.
Circulation|March 1, 1996
Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosisW R Huckle, M D Drag, W R Acker, et al.
Life Sciences|January 1, 1996
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonistD L Williams, K L Murphy, N A Nolan, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Metabolic stabilization of benzylidene ketal M(2) muscarinic receptor antagonists via halonaphthoic acid substitutionC D Boyle, S Chackalamannil, J W Clader, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.
Nature|November 20, 1980
A new class of angiotensin-converting enzyme inhibitorsA A Patchett, E Harris, E W Tristram, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamidesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|November 12, 1993
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylatesW T Ashton, S M Hutchins, W J Greenlee, et al.
European Journal of Pharmacology|December 29, 1995
In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptorsS D Kivlighn, G J Zingaro, R A Gabel, et al.
Circulation|March 1, 1996
Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosisW R Huckle, M D Drag, W R Acker, et al.
Life Sciences|January 1, 1996
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonistD L Williams, K L Murphy, N A Nolan, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Metabolic stabilization of benzylidene ketal M(2) muscarinic receptor antagonists via halonaphthoic acid substitutionC D Boyle, S Chackalamannil, J W Clader, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.
Nature|November 20, 1980
A new class of angiotensin-converting enzyme inhibitorsA A Patchett, E Harris, E W Tristram, et al.
Pageof 4